C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/505 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01)
Patent
CA 2257200
Compounds represented by formula (I) are disclosed. AR represents an aromatic group containing 6-10 atoms; and (a) represents a 4 to 10 membered non-aromatic heterocycle containing at least one N atom, and optionally containing 1-2 additional N atoms and 0-1 O or S atom. A pharmaceutical composition is also included. Methods of treating cancer and cytokine mediated diseases are also included.
L'invention concerne des composés représentés par la formule (I). Dans la formule, AR représente un groupe aromatique de 6 à 10 atomes; (a) représente un hétérocycle non aromatique à 4 ou 10 éléments comprenant au moins un atome de N et, facultativement, un ou deux atomes supplémentaires de N et 0 ou 1 atome de O ou S. On décrit par ailleurs une composition pharmaceutique et des procédés pour le traitement du cancer et des maladies à médiation cytokinique.
Bilodeau Mark T.
Butcher John W.
Claremon David A.
Liverton Nigel J.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Substituted imidazoles having cytokine inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles having cytokine inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles having cytokine inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2002048